178315-36-1 Usage
Molecular Structure
A unique structure consisting of an isoindolone ring fused with a phenethylamine moiety.
Ring System
Contains an isoindole ring, which is a fused benzene and pyrrole ring system.
Dihydroxy Substituent
Has two hydroxy groups (-OH) on the phenyl ring, contributing to its chemical reactivity and properties.
Methoxy Substituent
Features a methoxy group (-OCH3) on the phenyl ring, which can influence its solubility, stability, and biological activity.
Phenylethylamine Moiety
Contains a phenylethylamine group, which is a basic structural element found in various neurotransmitters and alkaloids.
Potential Pharmaceutical Applications
Due to its structural features, this compound may have various pharmacological activities, such as antioxidant, anti-inflammatory, and analgesic effects.
Further Research
More studies and research are needed to explore the full potential and applications of this chemical compound in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 178315-36-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,3,1 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 178315-36:
(8*1)+(7*7)+(6*8)+(5*3)+(4*1)+(3*5)+(2*3)+(1*6)=151
151 % 10 = 1
So 178315-36-1 is a valid CAS Registry Number.
178315-36-1Relevant articles and documents
Formation of spiro indane derivatives from hydroxy lactams derived from N-(1-phenylethyl)-phthalimide and -pyridine-2,3-dicarboximide
Bahajaj, Abood A.,Vernon, John M.
, p. 1041 - 1046 (2007/10/03)
Spiro[indane-1,7′-pyrrolo[3,4-b]pyridin]-5′-ones 18-22 are formed by acid-catalysed rearrangement from 7-aryl-7-hydroxy-6-(1-phenylethyl)-6,7-dihydropyrrolo[3,4-b]pyridin-5-ones. Further spiro indanes 39, 43 and 44 and spiro naphthalenes 41, 42, 45 and 46 are obtained from 3-(ω-phenylalkyl)-3-hydroxy-2-(1-phenylethyl)isoindolin-1-ones or from 7-(ω-phenylalkyl)-7-hydroxy-6-(1-phenylethyl)-6,7-dihydropyrrolo[3,4-b] pyridin-5-ones via α,α-cyclisation of N-acyliminium ion intermediates.
